Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for ArsenalBio

    Client Virtual Booth

    ARSENALBIO

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    ArsenalBio
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    571 Eccles Avenue South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.arsenalbio.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/aresnalbio
    Twitter
    Twitter
    https://twitter.com/arsenalbio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    ArsenalBio Announces Presentations Highlighting Data on AB-1015
    ArsenalBio Announces Presentations Highlighting Data on AB-1015

    https://www.businesswire.com/news/home/20230516005255/en

    BUSINESSWIRE
    16 May 2023
    Share Share
    ArsenalBio Announces Presentation of Six Abstracts at AACR
    ArsenalBio Announces Presentation of Six Abstracts at AACR

    https://www.businesswire.com/news/home/20230414005113/en

    BUSINESSWIRE
    14 Apr 2023
    Share Share
    Thermo Fisher, Arsenal Partner to Manufacture Autologous T-Cell Therapies
    Thermo Fisher, Arsenal Partner to Manufacture Autologous T-Cell Therapies

    https://www.contractpharma.com/contents/view_breaking-news/2023-03-29/thermo-fisher-arsenal-biosciences-partner-to-manufacture-autologous-t-cell-therapies/?widget=listSection

    CONTRACT PHARMA
    29 Mar 2023
    Share Share
    ArsenalBio Announces First Patient Dosed in Phase 1 Clinical Trial of AB-1015
    ArsenalBio Announces First Patient Dosed in Phase 1 Clinical Trial of AB-1015

    https://www.businesswire.com/news/home/20230105005145/en

    BUSINESSWIRE
    05 Jan 2023
    Share Share
    ArsenalBio lands $70M deal with cancer giant Genentech to develop cell therapy
    ArsenalBio lands $70M deal with cancer giant Genentech to develop cell therapy

    https://endpts.com/arsenalbio-lands-70m-cash-deal-with-cancer-giant-genentech-to-develop-cell-therapy/

    Aayushi Pratap ENDPTS
    28 Sep 2022
    Share Share
    Arsenal Biosciences Announces Joint Discovery Collaboration with Genentech
    Arsenal Biosciences Announces Joint Discovery Collaboration with Genentech

    https://www.businesswire.com/news/home/20220927005014/en

    BUSINESSWIRE
    27 Sep 2022
    Share Share
    Arsenal Biosciences Closes $220 Million Series B Financing to Advance Programmable Cell Therapy Programs into Clinical Development
    Arsenal Biosciences Closes $220 Million Series B Financing to Advance Programmable Cell Therapy Programs into Clinical Development

    https://www.pharmacompass.com/pdf/news/arsenal-biosciences-closes-220-million-series-b-financing-to-advance-programmable-cell-therapy-programs-into-clinical-development-1662707083.pdf

    PRESS RELEASE
    07 Sep 2022
    Share Share
    BMS-backed Arsenal Bio raises $220M touting refined cell therapy
    BMS-backed Arsenal Bio raises $220M touting refined cell therapy

    https://www.fiercebiotech.com/biotech/bms-backed-arsenal-bio-raises-220m-series-b-touting-potential-fleet-gene-edited-cell

    Max Bayer FIERCEBIOTECH
    06 Sep 2022
    Share Share
    Arsenal Biosciences to Present at the 2022 Jefferies Healthcare Conference
    Arsenal Biosciences to Present at the 2022 Jefferies Healthcare Conference

    https://www.businesswire.com/news/home/20220602005352/en

    BUSINESSWIRE
    02 Jun 2022
    Share Share
    Bristol Myers inks $3B in Century, ArsenalBio cell therapy deals
    Bristol Myers inks $3B in Century, ArsenalBio cell therapy deals

    https://www.fiercebiotech.com/biotech/bristol-myers-signs-3b-biobucks-deal-century-for-cell-therapies-for-hematologic-solid

    K. LaHucik FIERCEBIOTECH
    11 Jan 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search